Chrissy Teigen Partners with Cord Blood Registry®
CooperSurgical has launched an educational campaign featuring Chrissy Teigen to promote the benefits of banking newborn stem cells via Cord Blood Registry (CBR). The campaign emphasizes the potential medical benefits of cord blood and tissue, including emerging regenerative medicine applications. CBR stands as the largest family newborn stem cell preservation company globally, with over 700 samples released for transplants and therapies. Teigen's partnership aims to resonate with parents, as she highlights the importance of accessing current and future treatments for children. The initiative will utilize various media channels to inform families about this vital option.
- Partnership with Chrissy Teigen for a relatable and engaging educational campaign.
- CBR is the largest newborn stem cell preservation company, enhancing its market position.
- Campaign highlights the potential medical benefits of banked stem cells, particularly in regenerative medicine.
- None.
Educational campaign will highlight why parents should Bank on CBR™
Experience the full interactive Multichannel News Release here: https://www.multivu.com/players/English/9138651-bank-on-cbr/
"As part of my pregnancy, I learned banking my baby's newborn stem cells gives us access to current treatments and future clinical therapies, if my child ever needs them. We knew this was something we wanted to do – as a mom, I want to make sure our children have every possible option available to them," stated
This new, multichannel direct-to-consumer campaign, featuring
These powerful cells have the natural ability to turn into other types of important cells. Emerging research in regenerative medicine is examining the ability of newborn stem cells to also help repair and regenerate damaged cells with healthy ones. In fact,
"When we were identifying campaign partners,
To learn more about CBR and the campaign featuring
About CBR by CooperSurgical
Cord Blood Registry® (CBR®) is the largest family newborn stem cell preservation company in the world, helping parents store stem cells from cord blood and cord tissue for their children. Founded in 1994, CBR is the #1 choice for parents and most recommended by OB/GYNs for newborn stem cell preservation. The company has released over 700 samples intended for use in transplant medicine and regulated investigational regenerative medicine applications. CBR is here to help expand the possibilities of what newborn stem cell therapies can do for families and give parents the confidence to Bank on CBRÔ. More information can be found at www.cordblood.com.
About CooperSurgical
CooperSurgical is a leading fertility and women's healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most in life. CooperSurgical is at the forefront of delivering innovative assisted reproductive technology and genomic solutions that enhance the work of ART professionals to the benefit of families. We currently offer over 600 clinically relevant medical devices to women's healthcare providers, including testing and treatment options.
CooperSurgical is a wholly-owned subsidiary of CooperCompanies (NYSE: COO). CooperSurgical, headquartered in
About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in
Contact:
CooperSurgical
EvolveMKD
csi@evolvemkd.com
View original content:https://www.prnewswire.com/news-releases/chrissy-teigen-partners-with-cord-blood-registry-301741244.html
SOURCE CooperSurgical®
